nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—ADORA2B—prostate gland—prostate cancer	0.0299	0.14	CbGeAlD
Enprofylline—PDE4A—prostate gland—prostate cancer	0.0267	0.125	CbGeAlD
Enprofylline—ADORA2B—urethra—prostate cancer	0.02	0.094	CbGeAlD
Enprofylline—PDE4B—prostate gland—prostate cancer	0.0159	0.0746	CbGeAlD
Enprofylline—ADORA1—renal system—prostate cancer	0.0146	0.0687	CbGeAlD
Enprofylline—ADORA1—urethra—prostate cancer	0.0144	0.0675	CbGeAlD
Enprofylline—ADORA2B—testis—prostate cancer	0.0132	0.0618	CbGeAlD
Enprofylline—PDE4A—testis—prostate cancer	0.0117	0.0551	CbGeAlD
Enprofylline—ADORA2A—testis—prostate cancer	0.011	0.0514	CbGeAlD
Enprofylline—Theophylline—PDE4D—prostate cancer	0.0108	0.316	CrCbGaD
Enprofylline—PDE4B—urethra—prostate cancer	0.0106	0.0499	CbGeAlD
Enprofylline—ADORA1—testis—prostate cancer	0.00947	0.0444	CbGeAlD
Enprofylline—PDE4A—lymph node—prostate cancer	0.00851	0.0399	CbGeAlD
Enprofylline—PDE4B—bone marrow—prostate cancer	0.00819	0.0384	CbGeAlD
Enprofylline—Theobromine—CYP2E1—prostate cancer	0.00701	0.206	CrCbGaD
Enprofylline—PDE4B—testis—prostate cancer	0.007	0.0329	CbGeAlD
Enprofylline—ADORA1—lymph node—prostate cancer	0.00686	0.0322	CbGeAlD
Enprofylline—Theophylline—CYP1B1—prostate cancer	0.00671	0.197	CrCbGaD
Enprofylline—PDE4B—lymph node—prostate cancer	0.00508	0.0238	CbGeAlD
Enprofylline—Theophylline—CYP2E1—prostate cancer	0.00367	0.108	CrCbGaD
Enprofylline—Theophylline—CYP1A1—prostate cancer	0.00362	0.106	CrCbGaD
Enprofylline—Theophylline—CYP3A4—prostate cancer	0.00231	0.0678	CrCbGaD
Enprofylline—ADORA1—Signaling Pathways—LEP—prostate cancer	0.000119	0.000158	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PIK3CB—prostate cancer	0.000118	0.000157	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—BAD—prostate cancer	0.000118	0.000157	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CAV1—prostate cancer	0.000118	0.000156	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—LEP—prostate cancer	0.000117	0.000156	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CREBBP—prostate cancer	0.000117	0.000155	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—KDR—prostate cancer	0.000116	0.000154	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CAV1—prostate cancer	0.000116	0.000154	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IGF1—prostate cancer	0.000115	0.000153	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—KDR—prostate cancer	0.000115	0.000153	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—EGFR—prostate cancer	0.000115	0.000152	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—APC—prostate cancer	0.000114	0.000152	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CG—prostate cancer	0.000114	0.000152	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF1R—prostate cancer	0.000114	0.000151	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CXCL8—prostate cancer	0.000113	0.000151	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ESR1—prostate cancer	0.000113	0.00015	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EGF—prostate cancer	0.000113	0.00015	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IRS1—prostate cancer	0.000113	0.00015	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—JAK2—prostate cancer	0.000113	0.00015	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ESR1—prostate cancer	0.000112	0.000149	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MAP2K1—prostate cancer	0.000111	0.000148	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CD—prostate cancer	0.000111	0.000147	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—BAD—prostate cancer	0.000111	0.000147	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GSK3B—prostate cancer	0.00011	0.000146	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—PIK3CA—prostate cancer	0.00011	0.000146	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SERPINE1—prostate cancer	0.000109	0.000145	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—LPL—prostate cancer	0.000109	0.000145	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—BAD—prostate cancer	0.000109	0.000145	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—IL2—prostate cancer	0.000108	0.000144	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—KRAS—prostate cancer	0.000108	0.000144	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PDGFRB—prostate cancer	0.000108	0.000144	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—INS—prostate cancer	0.000108	0.000144	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PIK3CB—prostate cancer	0.000107	0.000142	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—APC—prostate cancer	0.000107	0.000142	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CG—prostate cancer	0.000107	0.000142	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CREBBP—prostate cancer	0.000106	0.000141	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—FGF2—prostate cancer	0.000106	0.000141	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EGF—prostate cancer	0.000106	0.000141	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IRS1—prostate cancer	0.000106	0.000141	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CG—prostate cancer	0.000106	0.000141	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—APC—prostate cancer	0.000106	0.000141	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ITGB3—prostate cancer	0.000106	0.00014	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IGF1—prostate cancer	0.000105	0.000139	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EGF—prostate cancer	0.000105	0.000139	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IRS1—prostate cancer	0.000105	0.000139	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—NOS3—prostate cancer	0.000105	0.000139	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—EGFR—prostate cancer	0.000104	0.000138	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CXCL8—prostate cancer	0.000103	0.000137	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GSK3B—prostate cancer	0.000103	0.000136	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ERBB3—prostate cancer	0.000102	0.000136	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—FGFR2—prostate cancer	0.000102	0.000136	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—JAK2—prostate cancer	0.000102	0.000135	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GSK3B—prostate cancer	0.000101	0.000135	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—INS—prostate cancer	0.000101	0.000135	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MAP2K1—prostate cancer	0.000101	0.000134	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CD—prostate cancer	0.0001	0.000134	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—INS—prostate cancer	0.0001	0.000133	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—PIK3CA—prostate cancer	9.95e-05	0.000132	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—PIK3CA—prostate cancer	9.95e-05	0.000132	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SERPINE1—prostate cancer	9.94e-05	0.000132	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CREBBP—prostate cancer	9.92e-05	0.000132	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MDM2—prostate cancer	9.91e-05	0.000132	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL2—prostate cancer	9.85e-05	0.000131	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—KRAS—prostate cancer	9.84e-05	0.000131	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TERT—prostate cancer	9.81e-05	0.00013	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CREBBP—prostate cancer	9.81e-05	0.00013	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IGF1—prostate cancer	9.8e-05	0.00013	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ERBB2—prostate cancer	9.77e-05	0.00013	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—EGFR—prostate cancer	9.75e-05	0.00013	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IGF1—prostate cancer	9.68e-05	0.000129	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CB—prostate cancer	9.65e-05	0.000128	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—EGFR—prostate cancer	9.64e-05	0.000128	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—FGF2—prostate cancer	9.62e-05	0.000128	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—NOS3—prostate cancer	9.49e-05	0.000126	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MAP2K1—prostate cancer	9.47e-05	0.000126	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CD—prostate cancer	9.41e-05	0.000125	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HIF1A—prostate cancer	9.38e-05	0.000125	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MAP2K1—prostate cancer	9.36e-05	0.000124	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—PIK3CA—prostate cancer	9.32e-05	0.000124	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SERPINE1—prostate cancer	9.31e-05	0.000124	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CD—prostate cancer	9.3e-05	0.000124	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CXCL8—prostate cancer	9.27e-05	0.000123	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—JAK2—prostate cancer	9.22e-05	0.000123	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—KRAS—prostate cancer	9.21e-05	0.000122	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—PIK3CA—prostate cancer	9.21e-05	0.000122	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SERPINE1—prostate cancer	9.2e-05	0.000122	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—LEP—prostate cancer	9.16e-05	0.000122	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—KRAS—prostate cancer	9.1e-05	0.000121	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CAV1—prostate cancer	9.07e-05	0.000121	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CDKN1B—prostate cancer	9.05e-05	0.00012	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—PIK3CA—prostate cancer	9.04e-05	0.00012	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—FGF2—prostate cancer	9.01e-05	0.00012	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MDM2—prostate cancer	9e-05	0.00012	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—KDR—prostate cancer	8.97e-05	0.000119	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—AKT1—prostate cancer	8.95e-05	0.000119	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—FGF2—prostate cancer	8.9e-05	0.000118	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—NOS3—prostate cancer	8.89e-05	0.000118	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ERBB2—prostate cancer	8.88e-05	0.000118	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CASP3—prostate cancer	8.87e-05	0.000118	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL2—prostate cancer	8.86e-05	0.000118	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL6—prostate cancer	8.81e-05	0.000117	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—NOS3—prostate cancer	8.78e-05	0.000117	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CB—prostate cancer	8.76e-05	0.000116	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ESR1—prostate cancer	8.74e-05	0.000116	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CCND1—prostate cancer	8.64e-05	0.000115	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—JAK2—prostate cancer	8.64e-05	0.000115	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CTNNB1—prostate cancer	8.55e-05	0.000114	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—JAK2—prostate cancer	8.53e-05	0.000113	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—BAD—prostate cancer	8.53e-05	0.000113	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PIK3CA—prostate cancer	8.46e-05	0.000112	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MDM2—prostate cancer	8.43e-05	0.000112	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CXCL8—prostate cancer	8.42e-05	0.000112	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MMP9—prostate cancer	8.38e-05	0.000111	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PIK3CA—prostate cancer	8.36e-05	0.000111	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CDKN1A—prostate cancer	8.35e-05	0.000111	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PTEN—prostate cancer	8.34e-05	0.000111	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MDM2—prostate cancer	8.33e-05	0.000111	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ERBB2—prostate cancer	8.31e-05	0.00011	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CG—prostate cancer	8.26e-05	0.00011	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—APC—prostate cancer	8.26e-05	0.00011	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CDKN1B—prostate cancer	8.22e-05	0.000109	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ERBB2—prostate cancer	8.21e-05	0.000109	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CB—prostate cancer	8.2e-05	0.000109	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IRS1—prostate cancer	8.17e-05	0.000109	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EGF—prostate cancer	8.17e-05	0.000109	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—AKT1—prostate cancer	8.13e-05	0.000108	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—AKT1—prostate cancer	8.13e-05	0.000108	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CB—prostate cancer	8.1e-05	0.000108	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CASP3—prostate cancer	8.06e-05	0.000107	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL2—prostate cancer	8.04e-05	0.000107	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL6—prostate cancer	8e-05	0.000106	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—EP300—prostate cancer	7.95e-05	0.000106	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GSK3B—prostate cancer	7.93e-05	0.000105	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CXCL8—prostate cancer	7.88e-05	0.000105	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CCND1—prostate cancer	7.84e-05	0.000104	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—INS—prostate cancer	7.82e-05	0.000104	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CXCL8—prostate cancer	7.79e-05	0.000103	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CTNNB1—prostate cancer	7.77e-05	0.000103	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SRC—prostate cancer	7.73e-05	0.000103	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CDKN1B—prostate cancer	7.7e-05	0.000102	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CREBBP—prostate cancer	7.66e-05	0.000102	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—AKT1—prostate cancer	7.61e-05	0.000101	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MMP9—prostate cancer	7.61e-05	0.000101	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CDKN1B—prostate cancer	7.61e-05	0.000101	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CDKN1A—prostate cancer	7.59e-05	0.000101	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PTEN—prostate cancer	7.57e-05	0.000101	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IGF1—prostate cancer	7.57e-05	0.000101	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CASP3—prostate cancer	7.54e-05	0.0001	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL2—prostate cancer	7.53e-05	0.0001	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—EGFR—prostate cancer	7.53e-05	0.0001	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—VEGFA—prostate cancer	7.53e-05	0.0001	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—AKT1—prostate cancer	7.52e-05	0.0001	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL6—prostate cancer	7.5e-05	9.96e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—STAT3—prostate cancer	7.45e-05	9.9e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CASP3—prostate cancer	7.45e-05	9.9e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL2—prostate cancer	7.44e-05	9.89e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL6—prostate cancer	7.41e-05	9.84e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—AKT1—prostate cancer	7.38e-05	9.81e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CCND1—prostate cancer	7.34e-05	9.76e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MAP2K1—prostate cancer	7.31e-05	9.72e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CTNNB1—prostate cancer	7.27e-05	9.66e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CD—prostate cancer	7.27e-05	9.65e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CCND1—prostate cancer	7.26e-05	9.64e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EP300—prostate cancer	7.22e-05	9.59e-05	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PIK3CA—prostate cancer	7.2e-05	9.56e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SERPINE1—prostate cancer	7.19e-05	9.55e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CTNNB1—prostate cancer	7.19e-05	9.55e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MMP9—prostate cancer	7.13e-05	9.47e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—KRAS—prostate cancer	7.11e-05	9.45e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CDKN1A—prostate cancer	7.1e-05	9.44e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PTEN—prostate cancer	7.09e-05	9.42e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MMP9—prostate cancer	7.04e-05	9.36e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CDKN1A—prostate cancer	7.02e-05	9.33e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SRC—prostate cancer	7.02e-05	9.33e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PTEN—prostate cancer	7e-05	9.3e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—FGF2—prostate cancer	6.96e-05	9.24e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MYC—prostate cancer	6.93e-05	9.2e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—AKT1—prostate cancer	6.91e-05	9.19e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TGFB1—prostate cancer	6.91e-05	9.18e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—NOS3—prostate cancer	6.86e-05	9.11e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—VEGFA—prostate cancer	6.84e-05	9.08e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—AKT1—prostate cancer	6.83e-05	9.08e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—EGFR—prostate cancer	6.78e-05	9e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—STAT3—prostate cancer	6.77e-05	8.99e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EP300—prostate cancer	6.76e-05	8.98e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EP300—prostate cancer	6.68e-05	8.87e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—JAK2—prostate cancer	6.67e-05	8.86e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SRC—prostate cancer	6.57e-05	8.73e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PIK3CA—prostate cancer	6.54e-05	8.68e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MDM2—prostate cancer	6.51e-05	8.65e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SRC—prostate cancer	6.49e-05	8.63e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ERBB2—prostate cancer	6.42e-05	8.53e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—VEGFA—prostate cancer	6.4e-05	8.5e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—KRAS—prostate cancer	6.4e-05	8.5e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—STAT3—prostate cancer	6.34e-05	8.42e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CB—prostate cancer	6.33e-05	8.41e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—VEGFA—prostate cancer	6.33e-05	8.4e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MYC—prostate cancer	6.29e-05	8.36e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TGFB1—prostate cancer	6.27e-05	8.34e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—STAT3—prostate cancer	6.26e-05	8.32e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EGFR—prostate cancer	6.15e-05	8.17e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CXCL8—prostate cancer	6.09e-05	8.08e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CDKN1B—prostate cancer	5.94e-05	7.9e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MYC—prostate cancer	5.89e-05	7.82e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CA—prostate cancer	5.88e-05	7.81e-05	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—AKT1—prostate cancer	5.88e-05	7.81e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TGFB1—prostate cancer	5.88e-05	7.81e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CASP3—prostate cancer	5.82e-05	7.74e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MYC—prostate cancer	5.82e-05	7.73e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL2—prostate cancer	5.82e-05	7.73e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—KRAS—prostate cancer	5.81e-05	7.72e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TGFB1—prostate cancer	5.81e-05	7.71e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL6—prostate cancer	5.79e-05	7.69e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EGFR—prostate cancer	5.76e-05	7.65e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EGFR—prostate cancer	5.69e-05	7.56e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TP53—prostate cancer	5.69e-05	7.56e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CCND1—prostate cancer	5.67e-05	7.53e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CTNNB1—prostate cancer	5.61e-05	7.46e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MMP9—prostate cancer	5.5e-05	7.31e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CDKN1A—prostate cancer	5.48e-05	7.29e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PTEN—prostate cancer	5.47e-05	7.27e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—KRAS—prostate cancer	5.44e-05	7.23e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—KRAS—prostate cancer	5.38e-05	7.14e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CA—prostate cancer	5.34e-05	7.09e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—AKT1—prostate cancer	5.34e-05	7.09e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EP300—prostate cancer	5.22e-05	6.93e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL6—prostate cancer	5.21e-05	6.92e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TP53—prostate cancer	5.17e-05	6.86e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SRC—prostate cancer	5.07e-05	6.74e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CA—prostate cancer	5e-05	6.64e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—VEGFA—prostate cancer	4.94e-05	6.57e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CA—prostate cancer	4.94e-05	6.56e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—STAT3—prostate cancer	4.89e-05	6.5e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TP53—prostate cancer	4.84e-05	6.43e-05	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—AKT1—prostate cancer	4.8e-05	6.38e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TP53—prostate cancer	4.78e-05	6.35e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL6—prostate cancer	4.73e-05	6.28e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MYC—prostate cancer	4.55e-05	6.04e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TGFB1—prostate cancer	4.54e-05	6.03e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EGFR—prostate cancer	4.45e-05	5.91e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL6—prostate cancer	4.43e-05	5.88e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL6—prostate cancer	4.38e-05	5.81e-05	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—AKT1—prostate cancer	4.36e-05	5.79e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—KRAS—prostate cancer	4.2e-05	5.58e-05	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—AKT1—prostate cancer	4.08e-05	5.43e-05	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—AKT1—prostate cancer	4.04e-05	5.36e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CA—prostate cancer	3.86e-05	5.13e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TP53—prostate cancer	3.73e-05	4.96e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL6—prostate cancer	3.42e-05	4.54e-05	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—AKT1—prostate cancer	3.15e-05	4.19e-05	CbGpPWpGaD
